Does VONOPRAZAN Cause Interstitial lung disease? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Interstitial lung disease have been filed in association with VONOPRAZAN (VOQUEZNA). This represents 1.0% of all adverse event reports for VONOPRAZAN.
20
Reports of Interstitial lung disease with VONOPRAZAN
1.0%
of all VONOPRAZAN reports
7
Deaths
11
Hospitalizations
How Dangerous Is Interstitial lung disease From VONOPRAZAN?
Of the 20 reports, 7 (35.0%) resulted in death, 11 (55.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VONOPRAZAN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does VONOPRAZAN Cause?
Drug ineffective (305)
Off label use (188)
Gastrooesophageal reflux disease (162)
Nausea (138)
Diarrhoea (115)
Abdominal pain upper (107)
Dyspepsia (90)
Headache (80)
Abdominal distension (68)
Dizziness (68)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VONOPRAZAN Alternatives Have Lower Interstitial lung disease Risk?
VONOPRAZAN vs VONOPRAZAN FUMURATE
VONOPRAZAN vs VORAPAXAR
VONOPRAZAN vs VORASIDENIB
VONOPRAZAN vs VORETIGENE NEPARVOVEC-RZYL
VONOPRAZAN vs VORICONAZOLE